https://tno155inhibitor.com/as....sociation-of-the-ana
The analysis included 134 visits (median, 10 visits/dog; range, 2-11). Mild-moderate (CPCSS, 0-3) and extreme (CPCSS, ≥4) disease had been documented in 94 (70%) and 40 (30%) visits, respectively. In emergency visits (n=44; 33%) CPCSS (median, 5; range, 0-15) and DLA (median, 534 U/L; range, 63-7133) were greater (P .001 and P= .003, correspondingly) than in planned people (n=90; 67per cent; median, 1; range, 0-6 and median, 384 U/L; range, 49-3747, respectively). DGGR-lipase task was conne